Rapid Communication Clinical and Biochemical Characteristics of Familial Hyperalphalipoproteinemia Associated with Complete Deficiency of Cholesteryl Ester Transfer Activity*

Introduction Many epidemiological studies have demonstrated that elevated levels of high density lipoprotein (HDL)-cholesterol are negatively correlated with the incidence of coronary heart disease1-3), suggesting a role of HDL in preventing the development of atherosclerotic lesions4). Familial hyperalphalipoproteinemia has been considered to be a genetic disorder characterized by elevated levels of serum HDL-cholesterol5). We found two families of familial hyperalphalipoproteinemia with corneal opacification and coronary heart disease6,7). These probands showed very low activity of hepatic triglyceride lipase and abnormal cholesteryl ester net transfer. In addition, we reported three probands with familial hyperalphalipoproteinemia due to complete deficiency of cholesteryl ester transfer activity (CETA)8). These data suggest that familial hyperalphalipoproteinemia may include several disease entities which are different in their pathogenesis. Recently, we also found two other unrelated

[1]  S. Yamashita,et al.  Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity. A case report. , 1984, Atherosclerosis.

[2]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[3]  P. Kern Lipoprotein lipase and hepatic lipase , 1991 .

[4]  J. Gofman,et al.  Blood Lipids and Human Atherosclerosis , 1950, Circulation.

[5]  S. Yamashita,et al.  Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. , 1988, Atherosclerosis.

[6]  E. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[7]  E. Gong,et al.  Characterization of human high-density lipoproteins by gradient gel electrophoresis. , 1981, Biochimica et biophysica acta.

[8]  M. Okazaki,et al.  Rapid method for the quantitation of cholesterol in human serum lipoproteins by high performance liquid chromatography. , 1981, Journal of biochemistry.

[9]  Y. Matsuzawa,et al.  Sensitive non-radioisotopic method for measuring lipoprotein lipase and hepatic triglyceride lipase in post-heparin plasma. , 1984, Clinical chemistry.

[10]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[11]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[12]  R. Jackson 5 Lipoprotein Lipase and Hepatic Lipase , 1983 .

[13]  C. Fielding,et al.  Cloning and sequencing of human cholesteryl ester transfer protein cDNA , 1987, Nature.

[14]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[15]  S. Moore,et al.  Pathogenesis of atherosclerosis. , 1985, Metabolism: clinical and experimental.

[16]  R. Mahley Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. , 1982, The Medical clinics of North America.

[17]  J. RMcNamara,et al.  Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. , 1987 .